The Amelia Platform

Amelia is an IP protected patent-pending medical device that can operate in thousands of healthcare locations, even those with limited resources.

• Amelia enables hundreds of complex clinical blood tests to be entirely self-administered by patients

• Tests take about 30 minutes

• Production costs are competitive with existing point-of-care solutions

• No oversight is required by a healthcare professional. Simply access a kiosk at your doctor’s office or clinic.

• Test results are immediately available to patients and healthcare providers

Amelia utilizes a novel electrochemical and microfluidic approach to testing. This cutting-edge science is validated by 100 peer-reviewed research articles.

• Amelia’s novel testing approach allows for automation and low sample volumes

• 1st clinical application of electrochemical microfluidic detection in blood diagnostics

• Applies the latest approaches to transdermal microneedle blood collection — validated from existing FDA cleared devices